Next Article in Journal
Perception of Policy and Environmental Action to Promote Healthy Behaviors in African American Communities
Previous Article in Journal
Correlation between Prenatal Exposure to Polybrominated Diphenyl Ethers (PBDEs) and Infant Birth Outcomes: A Meta-Analysis and an Experimental Study
Open AccessReview

Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?

by Junli Deng 1,2, Jie Tang 1,2, Guo Wang 1,2,* and Yuan-Shan Zhu 1,2,3,*
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China
Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA
Authors to whom correspondence should be addressed.
Academic Editor: William Chi-shing Cho
Int. J. Environ. Res. Public Health 2017, 14(3), 270;
Received: 3 February 2017 / Accepted: 24 February 2017 / Published: 7 March 2017
(This article belongs to the Section Global Health)
Whole genome transcriptomic analyses have identified numerous long non-coding RNA (lncRNA) transcripts that are increasingly implicated in cancer biology. LncRNAs are found to promote essential cancer cell functions such as proliferation, invasion, and metastasis, with the potential to serve as novel biomarkers of various cancers and to further reveal uncharacterized aspects of tumor biology. However, the biological and molecular mechanisms as well as the clinical applications of lncRNAs in diverse diseases are not completely understood, and remain to be fully explored. LncRNAs may be critical players and regulators in prostate cancer carcinogenesis and progression, and could serve as potential biomarkers for prostate cancer. This review focuses on lncRNA biomarkers that are already available for clinical use and provides an overview of lncRNA biomarkers that are under investigation for clinical development in prostate cancer. View Full-Text
Keywords: prostate cancer; lncRNAs; PCA3; biomarkers prostate cancer; lncRNAs; PCA3; biomarkers
Show Figures

Figure 1

MDPI and ACS Style

Deng, J.; Tang, J.; Wang, G.; Zhu, Y.-S. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference? Int. J. Environ. Res. Public Health 2017, 14, 270.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop